Report
Philip Gorham
EUR 850.00 For Business Accounts Only

Morningstar | Altria Misses in 1Q; Upside Remains But We Become Incrementally Less Optimistic about Medium Term. See Updated Analyst Note from 28 Apr 2019

We are lowering our fair value estimate for Altria to $58 from $62 after eliminating the assumption of EBI growth in stage 2 of our model. We already believed Altria's 2019 guidance of mid-single-digit adjusted EPS growth would be a stretch, and first-quarter results undershot consensus, driven by soft combustible volumes. The challenges facing Altria are reflected in our negative moat trend rating, but we still believe the firm can continue to generate economic profits for many years to come and we reiterate our wide moat rating. We retain near-term estimates below that of consensus, but we think there is upside to the stock following the market's negative reaction to the report.

The key question for investors is whether another soft quarter is indicative of a longer-term financial malaise. The underlying trend of cigarette volume declines has accelerated from 3% to 4% historically to 4% to 5% recently, but even after adjusting for channel inventory changes, management estimates industry volumes declined 7% in the first quarter. We do not recommend investors read too much into the volume data from any given quarter, but it is becoming increasingly difficult to believe Altria can sustain revenue and EBIT growth in the face of volume decline acceleration. Share of the nicotine industry is moving away from cigarettes to vaping, and although Altria now has a 35% stake in JUUL, the market leader, the migration to vaping is sub-optimal for Altria because of its lower share of the category profit pool and because we expect vaping to be lower margin than premium cigarettes. Our base case assumption is that margins will mildly decline over the next five years due to negative mix and fading opportunities to cut costs. EBIT was roughly stable in the first quarter, despite the volume shortfall, and the adjusted margin was 360 basis points above that a year ago. It is doubtful, however, that such margin improvement will be sustainable beyond the next few years.
Underlying
Altria Group Inc

Altria Group is a holding company. The company's subsidiaries include: Philip Morris USA Inc., which is engaged in the manufacture and sale of cigarettes; John Middleton Co., which is engaged in the manufacture and sale of machine-made cigars and pipe tobacco; Sherman Group Holdings, LLC and its subsidiaries, which are engaged in the manufacture and sale of cigarettes and the sale of cigars; and UST LLC, which through its subsidiaries, including U.S. Smokeless Tobacco Company LLC and Ste. Michelle Wine Estates Ltd., is engaged in the manufacture and sale of smokeless tobacco products and wine. The products of the company's tobacco subsidiaries include smokeable tobacco products and machine-made cigars.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Philip Gorham

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch